JACC: CardioOncology - Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: The PROACT Clinical Trial
JACC Specialty Journals10/15/24 • 2 min
In this episode of the JACC: CardioOncology Podcast, Antonio Cannata discusses the PROACT clinical trial, which investigated the effectiveness of enalapril in preventing cardiac damage in breast cancer and lymphoma patients undergoing anthracycline therapy. Despite neutral results, the conversation delves into the challenges of defining myocardial injury and emphasizes the need for improved risk stratification and innovative trial designs in future research.
10/15/24 • 2 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/jacc-specialty-journals-416886/jacc-cardiooncology-preventing-cardiac-damage-in-patients-treated-for-76494747"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to jacc: cardiooncology - preventing cardiac damage in patients treated for breast cancer and lymphoma: the proact clinical trial on goodpods" style="width: 225px" /> </a>
Copy